PW MEDTECH - EXPECT STOCK TO DOUBLE FROM HERE!!!PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China. The company manufactures and sells infusion sets. wHAT IS SUPER INTERESTING IS THAT THE COMPANY OWNS 14% OF A US LISTED COMPANY CALLED CBPO AND THIS ALONE IS 3X THE CURREN
0.011 EUR
20.32 M EUR
103.63 M EUR
395.67 M
About PW Medtech Group Ltd.
Sector
Industry
CEO
Yue E Zhang
Website
Headquarters
Beijing
Founded
2011
ISIN
KYG7306W1087
FIGI
BBG005M0HDB4
PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. It operates through the following segments: Infusion Set Business, Blood Purification Business, and Regenerative Medical Biomaterials Business. The Infusion Set Business segment represents the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. The Blood Purification Business segment represents the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. The Regenerative Medical Biomaterials Business” segment represents the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The company was founded on May 13, 2011 and is headquartered in Beijing, China.
Related stocks
PW Medtech- Undervalued stock worth >3x the current market cap! PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China. The company manufactures and sells infusion sets. CBPO is a blood plasma products firm in China with a U.S. stock listing. It is one of the top three producers of plasma p
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PW Medtech Group Ltd. stocks are traded under the ticker PWE.
Yes, you can track PW Medtech Group Ltd. financials in yearly and quarterly reports right on TradingView.
PWE net income for the last half-year is 7.66 M EUR, while the previous report showed 10.86 M EUR of net income which accounts for −29.45% change. Track more PW Medtech Group Ltd. financial stats to get the full picture.
PW Medtech Group Ltd. dividend yield was 9.80% in 2024, and payout ratio reached 92.54%. The year before the numbers were 12.01% and 91.12% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 9, 2025, the company has 1.42 K employees. See our rating of the largest employees — is PW Medtech Group Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PW Medtech Group Ltd. EBITDA is 31.35 M EUR, and current EBITDA margin is 32.70%. See more stats in PW Medtech Group Ltd. financial statements.
Like other stocks, PWE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PW Medtech Group Ltd. stock right from TradingView charts — choose your broker and connect to your account.


